IRIS
COPPOLA, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.160
EU - Europa 7.662
AS - Asia 1.413
SA - Sud America 25
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 17.290
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.136
IE - Irlanda 3.109
IT - Italia 1.021
UA - Ucraina 955
GB - Regno Unito 818
DE - Germania 728
SG - Singapore 635
CN - Cina 460
FI - Finlandia 282
GR - Grecia 250
SE - Svezia 213
TR - Turchia 210
FR - Francia 113
BE - Belgio 43
KR - Corea 41
NL - Olanda 37
CZ - Repubblica Ceca 27
IN - India 20
PL - Polonia 15
HK - Hong Kong 13
RS - Serbia 13
CA - Canada 11
RU - Federazione Russa 11
BR - Brasile 10
EU - Europa 9
IR - Iran 9
MX - Messico 9
MK - Macedonia 6
AT - Austria 5
ET - Etiopia 5
AR - Argentina 4
BO - Bolivia 4
DK - Danimarca 4
ES - Italia 4
PK - Pakistan 4
EG - Egitto 3
ID - Indonesia 3
JP - Giappone 3
PE - Perù 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
CD - Congo 2
CM - Camerun 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
MY - Malesia 2
NZ - Nuova Zelanda 2
UG - Uganda 2
VE - Venezuela 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
GT - Guatemala 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
PA - Panama 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 17.290
Salva come PNG Salva come JPEG
Città #
Dublin 3.107
Jacksonville 1.474
Chandler 1.014
Wilmington 547
Chicago 535
Santa Clara 497
Princeton 411
Singapore 382
Falls Church 345
Roxbury 319
Bremen 315
Ann Arbor 221
Cambridge 212
Medford 212
Caserta 197
New York 193
Boardman 155
Naples 117
Beijing 111
Woodbridge 111
San Mateo 99
Ashburn 98
Des Moines 90
Houston 89
Munich 60
Mountain View 50
Jinan 47
Nanjing 44
Helsinki 43
Napoli 43
Brussels 41
Seoul 41
Düsseldorf 37
Washington 36
Los Angeles 30
Milan 29
Auburn Hills 28
Istanbul 28
Rome 26
Brno 25
Marano 24
Amsterdam 23
Shenyang 22
Aversa 21
Nanchang 21
Norwalk 20
Kunming 18
Lappeenranta 15
Zhengzhou 15
Hangzhou 14
Kraków 14
Redwood City 14
Hebei 13
Dearborn 12
Venice 12
Grafing 11
Guangzhou 11
Ariano Irpino 10
Hong Kong 10
Lanzhou 10
London 10
Groningen 9
Ningbo 9
Altamura 8
Bari 8
Hefei 8
Salerno 8
Tianjin 8
Catania 7
Jiaxing 7
Marano Di Napoli 7
Paris 7
Seattle 7
Zanjan 7
Changsha 6
Guadalajara 6
Haikou 6
Shanghai 6
Boydton 5
Fairfield 5
Leawood 5
Nocera Inferiore 5
Putignano 5
San Lazzaro di Savena 5
San Nicola la Strada 5
Sant'anastasia 5
Sennori 5
Taizhou 5
Vienna 5
Bagheria 4
Belgrade 4
Bologna 4
Cercola 4
Cesa 4
Como 4
Fuzhou 4
Hanover 4
La Paz 4
Limbiate 4
Marco 4
Totale 12.002
Salva come PNG Salva come JPEG
Nome #
The role of bacterial colonization of the suture thread in early identification and targeted antibiotic treatment of surgical site infections: A prospective cohort study 1.311
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 113
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 108
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 92
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 87
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 86
Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study 86
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 86
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 82
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 80
Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? 80
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 79
An attempt to improve classification of HCV-correlated chronic hepatitis 77
Impact of comorbidities on the severity of chronic hepatitis B at presentation 77
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 76
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 75
PREVALENCE OF LATENT TUBERCULOSIS INFECTION IN HEALTHCARE WORKERS AT A HOSPITAL IN NAPLES, ITALY, A LOW-INCIDENCE COUNTRY 75
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 73
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 72
null 71
Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy 71
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 70
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 70
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 68
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 67
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 67
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 67
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 64
964 HBV occult infection in patients with chronic hepatitis C: a multicentric prospective study 63
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 63
Erratum: Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme (Journal of Occupational Medicine and Toxicology (2015) 10:41) 63
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 62
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 61
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 61
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 60
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 60
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 59
Does HIV infection favor the sexual transmission of hepatitis C? 59
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 59
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 59
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 59
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 59
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 59
Anti-HBc positività was associated with histological cirrhosis in patients with chronic hepatitis C 58
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 58
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 58
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 58
Suture thread check test for detection of surgical site contamination: a prospective study 58
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 57
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 57
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 57
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 57
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 56
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 56
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 56
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 55
Acute liver failure: a rare clinical presentation of visceral leishmaniasi 55
Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. 55
Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation 55
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 55
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 54
4. Infezioni da Salmonelle non-tifoidee: nuovi aspetti epidemiologici 54
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 54
[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME 54
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 54
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 54
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 53
Helicobacter spp. and liver diseases. 53
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 53
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 52
Absence of occult HCV infection in HIV-positive patients 52
Is the liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels? 51
Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases 51
Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant 51
Treatment of chronic HBV infection in developing countries. 51
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 51
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 51
Distribution pattern of hepatitis C Virus genotypes and correlation with viral load and risk factors in chronic positive patients 50
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 50
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 50
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 50
Can HCV affect the efficacy of anti-HIV treatment? 50
Clinical significance of hepatitis B surface antigen mutants 50
HBV vaccination status among healthcare workers: A cross-sectional study 50
Olfactory loss and brain connectivity after COVID-19 50
Clinical and virological characteristics associated with severe acute hepatitis B 49
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 49
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 49
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 49
Liver Histology in Patients With HBsAg Negative Anti-HBc and Anti-HCV Positive Chronic Hepatitis 48
Virological patterns of HCV patients with failure to interferon-free regimens. 48
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 48
HAV replication in acute hepatitis with typical and atypical clinical course 47
Asunaprevir, a protease inhibitor for the treatment of HCV infection 47
Role of genetic polymorphisms in hepatitis C virus chronic infection 47
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 47
Reply : Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer 46
RITUXIMAB-BASED TREATMENT, HCV REPLICATION AND HEPATIC FLARES 46
Hepatitis viruses and HIV infection in the Naples area 46
Anti-HCV IgG avidity index in acute hepatitis C. 46
Totale 7.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.008 0 0 0 0 260 72 338 99 121 50 58 10
2020/20212.200 173 18 234 87 377 59 333 271 48 266 292 42
2021/20223.228 179 157 255 126 810 61 155 63 101 242 228 851
2022/20235.603 549 179 374 305 632 325 10 249 2.757 34 99 90
2023/20242.347 180 82 132 175 821 243 31 63 27 33 157 403
2024/20251.060 51 87 57 203 662 0 0 0 0 0 0 0
Totale 18.120